fbpx

U.S. Anti-Doping Agency (USADA)

Click here to log in to the
Athlete Connect application

Click here to view your
test history and results

USADA logo with registered symbol.

Global DRO logo in whiteSearch Medications & Ingredients

Search
USADA Clean Sport Program and PFL Professional Fighters League co-logo.

Professional Fighters League

The Professional Fighters League (PFL) and the U.S. Anti-Doping Agency (USADA) are pleased to announce a five (5) year partnership to launch a robust and comprehensive anti-doping program for PFL athletes around the globe.

USADA will serve as the independent third-party administrator of PFL’s year-round Anti-Doping Policy beginning on July 11, 2023.

The Professional Fighters League (PFL) presents MMA for the first time in the sport-season format where individual fighters control their own destiny, competing in a regular season, playoffs, and championship. PFL’s differentiated format and exciting fights sparked breakout growth for the league. 

The PFL Season features elite MMA athletes across six weight classes, with each fighter having two fights during the PFL Regular Season.

Fighters earn regular season points based on their performance, with 3 points for a win, plus bonus points for knockouts and submissions. Each fighter is then seeded in standings for their weight class based on their point totals.

Following the Regular Season is the single-elimination PFL Playoffs which leads to the PFL World Championship. The winners of each title bout are crowned PFL World Champion of their respective weight class and earn $1 million. 

PFL ATHLETE RESOURCES

Click the icons below.

PFL Prohibited List
Whereabouts
Sample Collection Process
Therapeutic Use Exemptions
Results Management
Supplement Connect
Sanctions

USADA Play Clean Tip Center logo.

Report Doping

Athlete Connect logo.

Athlete Connect

Global DRO logo in white

Global Drug Reference Online

prohibited list

Click below to view the full PFL Prohibited List.

whereabouts

Click below to view the full PFL Whereabouts Policy.

Therapeutic Use Exemption Policy

Click below to view the full PFL Therapeutic Use Exemption (TUE) Policy.

Substance Inquiry

Please complete and submit the form below to determine if you need to apply for a TUE for your medication in question. A copy of this form will be sent to the email address entered below. If you do not receive a copy, please check your spam folder and/or resubmit the form and verify the email address is correct. Once this form is submitted successfully, you will receive a response from the USADA TUE and Drug Reference Department within 3-5 business days.

    Athlete Name:

    Date of Birth (mm/dd/yy):

    Sport Gender:

    Contact Email:

    Please verify that your email address is correct as a copy of this form will be sent to you.

    Contact Phone Number:

    Are you on the official 2025 PFL Season Roster?
    YesNoNot Sure

    Are you in the USADA PFL Testing Pool?
    YesNoNot Sure

    Please list all prohibited or conditional substances and medications you are currently taking. Please include the substance, dosage, route of administration, and frequency of the medications. Example: Albuterol (90mcg, inhaled, two puffs daily). You can check the status of your medication at Global DRO.

    Have you received any intravenous (IV) infusion or injection greater than a total volume of 100mL in 12 hours?
    YesNoNot Sure

    Treatment Duration:

    11. Please list your upcoming competition schedule and the states in which the fights will occur. (State athletic commissions may have differing policies)


    Click here for more information on USADA’s Privacy Policy.

    results management

    Click below to view the full PFL Arbitration Procedures.

    SANCTIONS

    View individual PFL sanction announcements.

    Athlete Connect

    Athlete Connect logo.

    Contact Athlete Connect

    (719) 785-2000

    Toll-Free: (866) 601-2632

    Email: clientservices@USADA.org

    CONTACT ATHLETE CONNECT

      Click here for more information on USADA’s Privacy Policy.